miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 21, Issue 9, Pages 1929-1943
Publisher
Wiley
Online
2017-04-15
DOI
10.1111/jcmm.13114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer
- (2016) NORIYUKI HAYASHI et al. ANTICANCER RESEARCH
- MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling
- (2016) Jian-Zhang Li et al. CANCER INVESTIGATION
- MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
- (2016) Xiaoming Liu et al. CURRENT CANCER DRUG TARGETS
- Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
- (2016) Doriana Fruci et al. CURRENT DRUG METABOLISM
- Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell
- (2016) Jiuda Zhao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44
- (2016) Jun-Mei Yi et al. MOLECULAR CANCER THERAPEUTICS
- Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies
- (2016) Kui Wang et al. PHARMACOLOGICAL RESEARCH
- The emerging role of miRNAs in combined cancer therapy
- (2015) Hong W Yu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD
- (2015) Jie Chai et al. IUBMB LIFE
- MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer
- (2015) Yan-Ying Xu et al. TUMOR BIOLOGY
- Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells
- (2014) Hua Zhu et al. Autophagy
- Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance
- (2014) Lin-Hai Yan et al. BMC CANCER
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Respiratory sensitizer hexamethylene diisocyanate inhibits SOD 1 and induces ERK-dependent detoxifying and maturation pathways in dendritic-like cells
- (2014) Ana Silva et al. FREE RADICAL BIOLOGY AND MEDICINE
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- RETRACTED ARTICLE: MicroRNA-495 mimics delivery inhibits lung tumor progression
- (2014) Cheng Ai et al. TUMOR BIOLOGY
- Effect of Repeated Oral Treatment with Etoposide on the Expression of Intestinal P-glycoprotein and Oral Morphine Analgesia
- (2014) Takuro Kobori et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- MicroRNAs as therapeutic targets in chemoresistance
- (2013) Michela Garofalo et al. DRUG RESISTANCE UPDATES
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- Rifampicin-Independent Interactions between the Pregnane X Receptor Ligand Binding Domain and Peptide Fragments of Coactivator and Corepressor Proteins
- (2011) Punya Navaratnarajah et al. BIOCHEMISTRY
- Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer
- (2011) R. De Souza et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites
- (2010) Doron Betel et al. GENOME BIOLOGY
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Mitogen-activated Protein Kinase Kinase Kinase 1 Protects against Nickel-induced Acute Lung Injury
- (2008) Maureen Mongan et al. TOXICOLOGICAL SCIENCES
- MicroRNAs: Control and Loss of Control in Human Physiology and Disease
- (2008) Min Li et al. WORLD JOURNAL OF SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started